Pamprin Multi-Symptom

Product NDC: 71687-3003
11-digit product format: 716873003
Labeler code: 71687
Product ID: 71687-3003_4fe8f1cd-8250-e908-e063-6394a90a1173
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen, Pamabrom, Pyrilamine maleate
Dosage form: TABLET
Route: ORAL
Labeler: Focus Consumer Healthcare, LLC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2016-06-01
Substance: PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN
Active strength: 15; 25; 500 mg/1; mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71687-3003-4	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71687-3003-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71687-3003-4	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71687-3003-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71687-3003-4	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71687-3003-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71687-3003-4	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71687-3003-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Pamprin Multi-Symptom
Brand name suffix: Maximum Strength
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
PYRILAMINE MALEATE	15 mg/1
PAMABROM	25 mg/1
ACETAMINOPHEN	500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R35D29L3ZA	Internal UNII lookup
UA8U0KJM72	Internal UNII lookup
362O9ITL9D	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1052637	Internal RxNorm lookup
1053852	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
60b3286d-5698-df50-e053-2991aa0afbe2	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
71687-3003-1	2025-04-14	Pamprin MultiSymptom
71687-3003-4	2025-04-14	Pamprin MultiSymptom
71687-3003-1	2025-01-30	Pamprin MultiSymptom
71687-3003-4	2025-01-30	Pamprin MultiSymptom

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71687-3003-1	Pamprin Multi-SymptomMaximum Strength	20 in 1 BOTTLE, PLASTIC	TABLET	20	5
71687-3003-1	Pamprin Multi-SymptomMaximum Strength	1 in 1 CARTON	TABLET	1	5
71687-3003-4	Pamprin Multi-SymptomMaximum Strength	1 in 1 CARTON	TABLET	1	5
71687-3003-4	Pamprin Multi-SymptomMaximum Strength	40 in 1 BOTTLE, PLASTIC	TABLET	40	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71687-3003	PAMPRIN MULTI-SYMPTOM MAXIMUM STRENGTH (ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE) TABLET [FOCUS CONSUMER HEALTHCARE, LLC]	4	Current NDC, Legacy NDC, 4 package rows	20250416_60b3286d-5698-df50-e053-2991aa0afbe2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 75 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lil Drug Store Aspirin 325	ASPIRIN	Lil Drug Store Products, Inc	de59aae2-f794-4243-acc8-37a10e27abde	2023-12-15	Warnings	Exact identifier application number: M013
Pain Reliever	ACETAMINOPHEN TABLET, EXTRA STRENGTH	Lil' Drug Store Products, Inc.	f0fdab5a-9d07-57aa-e053-2a95a90adc7f	2023-12-15	Warnings	Exact identifier application number: M013
BC Cherry	ASPIRIN AND CAFFEINE	Lil' Drug Store Products, Inc	79ea721b-d656-44f7-9d13-390debee7be0	2023-12-15	Warnings	Exact identifier application number: M013
Alka-Seltzer	BUFFERED ASPIRIN	Lil' Drug Store Products, Inc.	0c7a60e7-0bde-9aa2-e063-6294a90a3209	2023-12-14	Warnings	Exact identifier application number: M013
Circle K Aspirin 325	ASPIRIN	Lil Drug Store Products, Inc	4cd306e3-2119-4272-9da4-a848fe2746fa	2023-12-14	Warnings	Exact identifier application number: M013
Circle K Pain Reliever Extra Strength	ACETAMINOPHEN	Lil' Drug Store Products, Inc.	f2359bc3-901f-4ecb-b402-cb2fe404a935	2023-12-14	Warnings	Exact identifier application number: M013
Childrens Pain Relief	ACETAMINOPHEN	DISCOUNT DRUG MART	c55b8f9d-1396-43c0-acc9-5e3485eadb07	2023-12-08	Warnings	Exact identifier application number: M013
Childrens Pain Relief	ACETAMINOPHEN	DISCOUNT DRUG MART	775519ad-5683-451f-9bfc-5fafc70c68ec	2023-12-08	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	WALGREEN CO.	c20c814b-35f5-4c46-e053-2a95a90a50f2	2023-12-08	Warnings	Exact identifier application number: M013
Acetaminophen Extra Strength	ACETAMINOPHEN	Better Living Brands LLC	f9859be4-6d0b-2ab8-e053-6294a90aa862	2023-12-06	Warnings	Exact identifier application number: M013
Aurophen Regular Strength	ACETAMINOPHEN	KROGER COMPANY	b9b7b849-c3b3-9af7-e053-2a95a90a0077	2023-12-06	Warnings	Exact identifier application number: M013
Acetaminophen Regular Strength	ACETAMINOPHEN	KROGER COMPANY	cf649478-57d2-cc88-e053-2a95a90ad1ba	2023-12-06	Warnings	Exact identifier application number: M013
Acetaminophen Extra Strength	ACETAMINOPHEN	KROGER COMPANY	b9b6f878-1ec8-3dc0-e053-2995a90a5414	2023-12-06	Warnings	Exact identifier application number: M013
Pain Reliever	ACETAMINOPHEN	WALGREEN CO.	a48c522c-76c5-49f8-8c4d-3ee6b221e6f3	2023-12-06	Warnings	Exact identifier application number: M013
Pain Reliever	ACETAMINOPHEN	WALGREEN CO.	cc939a7c-ce56-5dd6-e053-2995a90aa8af	2023-12-06	Warnings	Exact identifier application number: M013
Alka-Seltzer Original Flavor	BUFFERED ASPIRIN, EFFERVESCENT TABLET	Lil' Drug Store Products, Inc.	ea5df8be-a08c-5fa3-e053-2995a90a0bac	2023-12-06	Warnings	Exact identifier application number: M013
Ringl	ACETAMINOPHEN	Sato Pharmaceutical Co., Ltd.	ba5a0286-3e0f-4bef-96e5-29d92f51f432	2023-12-06	Warnings	Exact identifier application number: M013
Pain Relief Childrens	ACETAMINOPHEN	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	41633554-474e-4d3c-9187-d90487d2ae8c	2023-12-06	Warnings	Exact identifier application number: M013
Acetaminophen Extra Strength	ACETAMINOPHEN	Family Dollar Stores, LLC	f86dcbb8-debc-4bce-e053-6294a90a7a02	2023-12-05	Warnings	Exact identifier application number: M013
Sanatos Multi Symptom Daytime	ACETAMINOPHEN, DEXTROMETHORPHAN HBR	Pharmadel LLC	0a5fc0ef-ba34-bb0b-e063-6394a90af7d9	2023-12-01	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R35D29L3ZA	PYRILAMINE MALEATE	59-33-6	PYRILAMINE MALEATE
UA8U0KJM72	PAMABROM	606-04-2	PAMABROM
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1052637	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	PSN	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	Pamprin Max Strength Multi-Symptom 500 MG / 25 MG / 15 MG Oral Tablet	PSN	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]	SBD	60b3286d-5698-df50-e053-2991aa0afbe2	5
1052637	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	SCD	60b3286d-5698-df50-e053-2991aa0afbe2	5
1052637	APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	APAP 500 MG / pamabrom 25 MG / Pyrilamine Maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	Pamprin Multi-Symptom (APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG) Oral Tablet	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
71687-3003-1	71687300301	1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in 1 BOTTLE, PLASTIC	2016-06-01	0000-00-00	No	No	Current
71687-3003-4	71687300304	1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in 1 BOTTLE, PLASTIC	2016-06-01	0000-00-00	No	No	Current